 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C23H38O2 |
| Molar mass | 346.555 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
O-1871 is a potentcannabinoid agonist which was invented by Billy R Martin and Raj K Razdan atOrganix Inc in 2002. It has aCB1 receptor affinity of 2.0 nM and aCB2 receptor affinity of 0.3 nM.[1] Structurally, O-1871 is a cyclohexylphenol derivative related toCP 47,497,[2] and so is illegal in some jurisdictions where CP 47,497 and its derivatives are banned. However the 3,3-dimethylcyclohexyl substituent of O-1871 can be replaced by various other groups, producing other potent compounds such as the cycloheptyl derivativeO-1656 and the 2-adamantyl derivative O-1660, as well as the corresponding 3,5-dichlorophenyl derivative,[3] which are not cyclohexylphenol derivatives.
 | Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it. |
